SC
DGX icon

Sawyer & Company’s Quest Diagnostics DGX Stock Holding History

Sawyer & Company’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$805K Sell
3,796
-295
-7% -$57.9K 0.27% 70
2026
Q1 		$802K Hold
4,091
– – 0.31% 65
2025
Q4 		$710K Sell
4,091
-297
-7% -$54.1K 0.25% 66
2025
Q3 		$788K Buy
4,388
+592
+16% +$105K 0.3% 67
2025
Q2 		$805K Sell
3,796
-682
-15% -$118K 0.27% 70
2025
Q1 		$758K Sell
4,478
-1,368
-23% -$225K 0.31% 65
2024
Q4 		$882K Sell
5,846
-2,168
-27% -$337K 0.33% 65
2024
Q3 		$1.24M Sell
8,014
-165
-2% -$24.6K 0.46% 61
2024
Q2 		$1.12M Sell
8,179
-139
-2% -$19K 0.45% 60
2024
Q1 		$1.11M Sell
8,318
-140
-2% -$18.2K 0.44% 62
2023
Q4 		$1.17M Sell
8,458
-1,200
-12% -$158K 0.51% 59
2023
Q3 		$1.18M Sell
9,658
-135
-1% -$18K 0.55% 57
2023
Q2 		$1.38M Hold
9,793
– – 0.63% 56
2023
Q1 		$1.4M Sell
9,793
-152
-2% -$21.7K 0.76% 50
2022
Q4 		$1.56M Buy
9,945
+2
+0% +$287 0.77% 49
2022
Q3 		$1.22M Hold
9,943
– – 0.67% 53
2022
Q2 		$1.32M Hold
9,943
– – 0.67% 50
2022
Q1 		$1.36M Sell
9,943
-8
-0.1% -$1.11K 0.61% 51
2021
Q4 		$1.72M Sell
9,951
-26
-0.3% -$3.96K 0.74% 47
2021
Q3 		$1.45M Sell
9,977
-15
-0.2% -$2.19K 0.68% 51
2021
Q2 		$1.32M Sell
9,992
-5
-0.1% -$655 0.62% 54
2021
Q1 		$1.28M Hold
9,997
– – 0.64% 51
2020
Q4 		$1.19M Sell
9,997
-54
-0.5% -$6.58K 0.61% 52
2020
Q3 		$1.15M Buy
10,051
+430
+4% +$50.8K 0.68% 48
2020
Q2 		$1.1M Buy
9,621
+3,615
+60% +$383K 0.68% 48
2020
Q1 		$482K Buy
6,006
+376
+7% +$38.9K 0.38% 65
2019
Q4 		$601K Sell
5,630
-350
-6% -$36.5K 0.39% 67
2019
Q3 		$640K Sell
5,980
-60
-1% -$6.16K 0.46% 63
2019
Q2 		$615K Hold
6,040
– – 0.41% 71
2019
Q1 		$543K Hold
6,040
– – 0.36% 75
2018
Q4 		$503K Hold
6,040
– – 0.37% 72
2018
Q3 		$652K Hold
6,040
– – 0.4% 74
2018
Q2 		$664K Hold
6,040
– – 0.43% 69
2018
Q1 		$606K Hold
6,040
– – 0.41% 70
2017
Q4 		$595K Buy
+6,040
New +$573K 0.39% 72

Other funds holding DGX

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
AIM
Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sawyer & Company's DGX Position: Q2 2026 in Review

Sawyer & Company reduced its Quest Diagnostics (DGX) stake by 7.2% in Q2 2026, selling an estimated $57.9K and leaving 3,796 shares worth $805K. The position accounts for 0.27% of the portfolio, ranked #70.

Sawyer & Company first reported a position in DGX in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.72M in Q4 2021. 444 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Sawyer & Company held 3,796 shares of Quest Diagnostics worth $805K as of Q2 2026.
  • Sawyer & Company sold 295 Quest Diagnostics shares in Q2 2026, an estimated $57.9K.
  • Quest Diagnostics made up 0.27% of Sawyer & Company's portfolio in Q2 2026, its #70 holding.
  • Sawyer & Company first reported a position in Quest Diagnostics in Q4 2017 and has held it in 35 quarters since.
  • Sawyer & Company's Quest Diagnostics position peaked at $1.72M in Q4 2021.
  • 444 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Sawyer & Company's 13F filing for Q2 2026, filed 23 Jul 2026.